LABD

Direxion Daily S&P Biotech Bear 3X Shares
*Unless otherwise stated, data provided by FactSet.

LABD Fund Description

LABD provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index.

LABD Factset Analytics Insight

LABD is a daily leveraged inverse (-3x) bet on an equal-weighted index of US biotech stocks. The vast majority of the fund's exposure is to biotechnology and medical research but also captures significant exposure to pharmaceuticals as well. As a leveraged product, the fund is not a buy-and-hold investment. It gets its leverage exposure through a through a portfolio of swaps that gets rebalanced at the end of each trading day. Because of that, the fund's return for periods longer than a day becomes path-dependent and is likely to be different from -3x the return of the index for the same period. This makes LABD suitable primarily for short-term traders. Over time, compounding effects can lead to profound differences in expected returns relative to the index.

PERFORMANCE [as of 07/23/21] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
LABD 10.40% 3.56% -11.40% -59.89% -62.69% -66.43% --
LABD (NAV) 15.68% 6.35% -8.48% -63.15% -62.45% -66.19% --
S&P Biotechnology Select Industry Index -5.70% -5.63% -10.03% 10.40% 8.40% 16.59% 17.73%
N/A -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

LABD Summary Data

Direxion
05/28/15
Open-Ended Fund
1.06%
$45.30M
0.10%
BIS

LABD Portfolio Data

5.48%
N/A

LABD Index Data

Equal
Market Cap
N/A

LABD Fund Structure

Yes
No
-- / --
N/A
N/A
Medium
-3
Daily

LABD Tax Exposures

20.00% / 39.60%
--
No

LABD Factset Analytics Block Liquidity

As of 07/26/21
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of LABD. LABD is rated a N/A out of 5.

LABD Tradability

2,540,877
$54.01M
2,380,923
$48.79M
0.10%
$0.02
-0.06%
1,892.70% / -0.92%
None
97.00%
50,000
47.62
0.00%
--
25,446
$23.11
N/A